PHEBRA POTASSIUM PHOSPHATE CONCENTRATED Injection

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

monobasic potassium phosphate, Quantity: 109.33 mg/mL; dibasic potassium phosphate, Quantity: 105.33 mg/mL

Commercializzato da:

Phebra Pty Ltd

Forma farmaceutica:

Injection, intravenous infusion

Composizione:

Excipient Ingredients: water for injections

Via di somministrazione:

Intravenous

Confezione:

10mL x 10

Tipo di ricetta:

Not scheduled. Not considered by committee

Indicazioni terapeutiche:

INDICATIONS AS AT 01 JANUARY 1991 : Treatment of severe hypophosphataemia (serum levels <0.3mmol/l) and other degrees of hypophosphataemia when oral therapy is not possible. Lowering the pH of urine. The treatment of potassium depletion in patients with hypokalemia. IV administration is indicated when the patient is unable to take potassium orally or if hypokalemia is severe.

Dettagli prodotto:

Visual Identification: Clear colourless solution; Container Type: Vial; Container Material: Glass; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

1991-10-14